New choices, new challenges: Anti-TNF versus anti-integrin molecule therapy in IBD

MeSH terms

• Adalimumab / adverse effects
• Adalimumab / pharmacology
• Adalimumab / therapeutic use
• Antibodies, Monoclonal, Humanized / adverse effects
• Antibodies, Monoclonal, Humanized / pharmacology*
• Antibodies, Monoclonal, Humanized / therapeutic use*
• Humans
• Immunosuppressive Agents / adverse effects
• Immunosuppressive Agents / pharmacology*
• Immunosuppressive Agents / therapeutic use*
• Inflammatory Bowel Diseases / drug therapy*
• Infliximab / adverse effects
• Infliximab / pharmacology
• Infliximab / therapeutic use
• Integrins / antagonists & inhibitors*
• Molecular Targeted Therapy / methods*
• Tumor Necrosis Factor-alpha / antagonists & inhibitors*